scholarly article | Q13442814 |
P50 | author | Dimitrios N Bikiaris | Q63993390 |
Dimitrios J Giliopoulos | Q88943056 | ||
Evangelos Karavas | Q123562021 | ||
Vassilios Karavelidis | Q123562029 | ||
P2093 | author name string | Sofia Papadimitriou | |
P2860 | cites work | Nanotechnology: intelligent design to treat complex disease | Q28246583 |
Novel biodegradable polyesters. Synthesis and application as drug carriers for the preparation of raloxifene HCl loaded nanoparticles. | Q33487116 | ||
Long-circulating and target-specific nanoparticles: theory to practice | Q34253450 | ||
Polymers in drug delivery | Q34318090 | ||
Biodegradable nanoparticles for drug and gene delivery to cells and tissue | Q35082117 | ||
Polymer architecture and drug delivery | Q36360121 | ||
The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis | Q36537033 | ||
Nanocarriers: promising vehicle for bioactive drugs | Q36583337 | ||
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. | Q36627730 | ||
Micellar nanocarriers: pharmaceutical perspectives | Q36655007 | ||
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. | Q36733054 | ||
Engineering biodegradable polyester particles with specific drug targeting and drug release properties | Q36920273 | ||
Methods for the preparation and manufacture of polymeric nanoparticles. | Q37358092 | ||
Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix | Q38549183 | ||
Biodegradable long-circulating polymeric nanospheres | Q38569096 | ||
Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release | Q39850721 | ||
Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers | Q40961272 | ||
Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers | Q42876909 | ||
Nanoencapsulation of a water soluble drug in biocompatible polyesters. Effect of polyesters melting point and glass transition temperature on drug release behavior | Q42878158 | ||
Effectiveness of various drug carriers in controlled release formulations of raloxifene HCl prepared by melt mixing | Q43277074 | ||
Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) amphiphilic triblock copolymer micelles | Q44062866 | ||
Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice | Q44828772 | ||
Correlation between chemical and solid-state structures and enzymatic hydrolysis in novel biodegradable polyesters. The case of poly(propylene alkanedicarboxylate)s | Q46161739 | ||
Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo | Q47297862 | ||
Effects of crystalline microstructure on drug release behavior of poly(ε-caprolactone) microspheres | Q51809991 | ||
Synthesis, cocrystallization, and enzymatic degradation of novel poly(butylene-co-propylene succinate) copolymers | Q57186886 | ||
Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization | Q74825559 | ||
Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix | Q78225522 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanocarrier | Q17153796 |
P304 | page(s) | 3021-3032 | |
P577 | publication date | 2011-11-24 | |
P1433 | published in | International Journal of Nanomedicine | Q6051502 |
P1476 | title | Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior | |
P478 | volume | 6 |
Q58557425 | Amphiphilic Block Copolymer Microspheres Derived from Castor Oil, Poly(ε-carpolactone), and Poly(ethylene glycol): Preparation, Characterization and Application in Naltrexone Drug Delivery |
Q57793210 | Cationic Substitutions in Hydroxyapatite: Current Status of the Derived Biofunctional Effects and Their In Vitro Interrogation Methods |
Q58696457 | Chitosan Nanoparticles with Encapsulated Natural and UF-Purified Annatto and Saffron for the Preparation of UV Protective Cosmetic Emulsions |
Q33902253 | Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. |
Q26782780 | Drug Carrier for Photodynamic Cancer Therapy |
Q52601406 | Drug delivery systems and materials for wound healing applications. |
Q36176104 | Effects of pH-sensitive chain length on release of doxorubicin from mPEG-b-PH-b-PLLA nanoparticles |
Q36079945 | Formation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2. |
Q35100738 | Redox potential ultrasensitive nanoparticle for the targeted delivery of camptothecin to HER2-positive cancer cells |
Q93081684 | Selectively Biodegradable Polyesters: Nature-Inspired Construction Materials for Future Biomedical Applications |
Q38821629 | Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells |
Q38643438 | Thermomechanical Properties of Polylactic Acid-Graphene Composites: A State-of-the-Art Review for Biomedical Applications |
Search more.